A new strategic guide, intended to help manufacturers bring rare disease products to market, has been launched to mark Rare Disease Day (February 28).
In the guide, Terebellum (a subsidiary of AscellaHealth) shares tips on how industry stakeholders can create an effective market access strategy, giving their treatment the best chance of success in a competitive sector.
Features will include why a market access strategy is important and how to develop one effectively, how to build product value, as well as insight into best practices for identifying population size and determining pricing. Readers can also learn which external partners to approach and what specialist knowledge they can acquire to bolster their own teams.
Craig Caceci, Terebellum’s Managing Director, commented: “Bringing any product to market, particularly those used to treat rare and orphan diseases is a challenge enough. But given low patient prevalence, lack of understanding about these diseases and tight budgets, there’s no guarantee your product – however needed it is – will make it to market.
“We understand that companies are up against treatments for a whole range of diseases, all competing for the same budget or funding. However, our new guide explains steps you can take to give yourself the best chance – especially when having a patient for the drug doesn’t necessarily guarantee that your product will enter the market and be paid for.”
